
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Author(s) -
Stephanie I. Kim,
Andy H. Szeto,
Katherine P. Morgan,
Blaine Brower,
Mary Dunn,
Amir H. Khandani,
Paul A. Godley,
Tracy L. Rose,
Ethan Basch,
Matthew I. Milowsky,
Young E. Whang,
Daniel J. Crona
Publication year - 2021
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0262326
Subject(s) - enzalutamide , abiraterone , prostate cancer , radium 223 , medicine , oncology , abiraterone acetate , cancer , androgen deprivation therapy , androgen receptor , bone metastasis